Market open
Axonics Modulation Technologies/$AXNX
14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX
About Axonics Modulation Technologies
Axonics Inc is a United States-based medical technology company. It focuses on developing and commercializing novel products for adults with bladder and bowel dysfunction, that include implantable SNM systems to treat urinary urge incontinence and urinary urgency frequency (UUF); a urethral bulking agent (Bulkamid) to treat female stress urinary incontinence. SNM therapy is predominantly used to treat patients with overactive bladder, fecal incontinence, and urinary retention. Geographically, the company generates majority of its revenue from United States and rest from International markets.
Ticker
$AXNX
Sector
Trading on
Industry
Health Care Equipment & Supplies
Headquarters
Employees
797
Website
AXNX Metrics
BasicAdvanced
$3.6B
Market cap
-
P/E ratio
-$0.03
EPS
0.83
Beta
-
Dividend rate
Price and volume
Market cap
$3.6B
Beta
0.83
52-week high
$70.39
52-week low
$49.70
Average daily volume
463K
Financial strength
Current ratio
8.956
Quick ratio
7.007
Long term debt to equity
4.73
Total debt to equity
5.045
Interest coverage (TTM)
-5.39%
Management effectiveness
Return on assets (TTM)
-0.46%
Return on equity (TTM)
-0.28%
Valuation
Price to revenue (TTM)
8.642
Price to book
5.59
Price to tangible book (TTM)
7.68
Price to free cash flow (TTM)
186.747
Growth
Revenue change (TTM)
27.81%
Earnings per share change (TTM)
-94.84%
3-year revenue growth (CAGR)
39.60%
3-year earnings per share growth (CAGR)
-72.80%
What the Analysts think about AXNX
Analyst Ratings
Analyst ratings (Buy, Hold, Sell) for Axonics Modulation Technologies stock.
AXNX Financial Performance
Income Statement
Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%
AXNX Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
AXNX News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for Axonics Modulation Technologies stock?
Axonics Modulation Technologies (AXNX) has a market cap of $3.6B as of November 08, 2024.
What is the P/E ratio for Axonics Modulation Technologies stock?
The price to earnings (P/E) ratio for Axonics Modulation Technologies (AXNX) stock is 0 as of November 08, 2024.
Does Axonics Modulation Technologies stock pay dividends?
No, Axonics Modulation Technologies (AXNX) stock does not pay dividends to its shareholders as of November 08, 2024.
When is the next Axonics Modulation Technologies dividend payment date?
Axonics Modulation Technologies (AXNX) stock does not pay dividends to its shareholders.
What is the beta indicator for Axonics Modulation Technologies?
Axonics Modulation Technologies (AXNX) has a beta rating of 0.83. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.